[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial]. / Effetti della dose degli agenti stimolanti l'eritropoiesi su esiti cardio-cerebrovascolari, qualità di vita e costi in emodialisi.
G Ital Nefrol
; 30(2)2013.
Article
de It
| MEDLINE
| ID: mdl-23832463
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Dialyse rénale
/
Antianémiques
/
Anémie
Type d'étude:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Health_economic_evaluation
/
Observational_studies
/
Risk_factors_studies
/
Systematic_reviews
Aspects:
Patient_preference
Limites:
Female
/
Humans
/
Middle aged
Langue:
It
Journal:
G Ital Nefrol
Sujet du journal:
NEFROLOGIA
Année:
2013
Type de document:
Article
Pays de publication:
Italie